This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult your healthcare provider before starting any supplement, especially if you take prescription medications or have existing health conditions.
By Kim Larson, Health and Wellness Expert | TotalHealthRD.com
The Question That Lands in Our Inbox More Than You'd Expect
The question arrives in different forms, but the underlying concern is consistent: a husband, partner, or household member has been taking a male vitality gummy, or you've seen one advertised heavily and wondered whether the botanical stack inside — ashwagandha, maca, L-arginine, tribulus terrestris, horny goat weed — is relevant to your own midlife wellness. Or you simply want to know whether “formulated for men” means anything in a DSHEA world where supplement categories are largely marketing constructs.
The answer requires separating a few distinct questions. The first is regulatory: are these products legally restricted to men? The second is physiological: do the specific ingredients have published research for women, and particularly for women navigating the hormonal and metabolic shifts of perimenopause and post-menopause? The third is practical: are there any ingredients in this category that present specific risks for midlife women, particularly those taking common medications?
This article addresses all three. It is not a review of a specific product. For the label-verified review of JellyFil specifically — one product in this category that has been marketed actively in mid-2026 — see our full analysis at JellyFil Review 2026: What the Label Shows.
Regulatory Reality: “For Men” Is a Marketing Label, Not a Regulatory Category
Under the Dietary Supplement Health and Education Act of 1994, dietary supplements do not require pre-market approval and are not categorized by intended gender. A product marketed as a “male vitality” supplement is not subject to different manufacturing standards, different ingredient restrictions, or different regulatory review than a supplement marketed for women. The FDA does not recognize “male vitality” as a regulated category. What this means practically: the ingredient list on a male vitality gummy is subject to the same DSHEA rules as any other supplement — structure/function claims permitted, disease claims prohibited, no proof of efficacy required before sale.
The “for men” framing is primarily a positioning and marketing decision. Brands in this category target men because the commercial market for male sexual health and vitality supplements is large. That targeting does not change what the ingredients do in a biological sense, and it does not mean women cannot or should not take these products. It means the research supporting the product's claims may have been conducted primarily in male subjects, and any assumptions about equivalence in women should be examined rather than assumed.
The Ingredients Most Common in Male Vitality Gummies: What the Research Shows for Women
The botanical stack most commonly found in male vitality gummies combines adaptogens, traditional botanical aphrodisiacs, an amino acid, and often a mild stimulant. Here is what the published research shows for each, with specific attention to women's midlife physiology.
Ashwagandha (Withania somnifera) is probably the most studied ingredient in this category for women. Published trials have examined ashwagandha root extract specifically in women for stress response, cortisol modulation, and sexual function. A 2015 study published in the Journal of the International Society of Sports Nutrition found significant reductions in cortisol and improvements in stress scores in adults generally. A separate pilot study published in BioMed Research International examined ashwagandha specifically in women with sexual dysfunction and found improvements in several measures. Research dosages have consistently been 300–600mg of standardized KSM-66 or Sensoril extract. The important caveat for any gummy product: if ashwagandha is one of nine ingredients sharing an 82mg proprietary blend, the per-serving ashwagandha content is a small fraction of what the studies used. This does not mean the ingredient has zero effect at lower doses, but dose-response assumptions from published research should not be automatically transferred to proprietary blend products.
Maca root (Lepidium meyenii) has specific published research in postmenopausal women. A 2008 randomized crossover study published in Menopause examined maca in early postmenopausal women and found improvements in depression and blood pressure measures. A 2015 pilot study in Climacteric examined maca for hot flashes and night sweats in perimenopausal women. The evidence base for maca in women is modest — these are small studies — but the ingredient is not without women-specific research, which is notably more than can be said for several others on this list. Research dosages for maca have ranged from 1.5 to 3.5 grams daily of whole maca powder. Concentrated extract doses are lower, but any amount within a small shared proprietary blend should be understood as a low-dose exposure relative to the research.
L-Arginine is an amino acid that serves as a precursor to nitric oxide, which supports vascular dilation. The cardiovascular research on L-arginine in women is less developed than in men, though nitric oxide pathways are relevant to both. In the context of a low-dose blend, L-arginine's contribution is limited relative to the gram-level dosages used in vascular research. For midlife women, the more clinically relevant consideration is whether L-arginine interacts with any cardiovascular medications — which it can, particularly nitrate-class drugs. See our safety article for the full interaction profile at Male Vitality Supplement Safety Guide 2026.
Tribulus Terrestris has been the subject of several trials in women, primarily for sexual function in postmenopausal women. A study published in the Journal of Sexual Medicine examined tribulus in women with hypoactive sexual desire and found modest improvements. The research in women is more developed than marketing typically acknowledges. Standard research dosages have been 250–750mg of standardized extract daily. Again, a fraction of an 82mg blend provides substantially less.
Horny Goat Weed (Epimedium) contains icariin, which has been studied in preclinical and some clinical contexts for bone support in postmenopausal women — a different application than its traditional “libido” positioning. Some research suggests icariin may act as a phytoestrogen. For midlife women with hormone-sensitive conditions, this is worth noting. For most women, the doses in a gummy proprietary blend are unlikely to produce meaningful estrogenic effects, but women with hormone-sensitive conditions should flag this with their provider.
Green Tea Extract is well-researched in mixed-sex populations for antioxidant support. The main midlife consideration is caffeine sensitivity and potential interaction with blood thinners (warfarin in particular has documented interactions with green tea).
Muira Puama and Catuaba Extracts are traditional Amazonian botanicals with limited published clinical research in any population. Published human trial evidence for either is sparse. These are included in male vitality formulas based on traditional use history rather than a robust evidence base.
What “Proprietary Blend” Means for Evaluating Research Applicability
Nearly every male vitality gummy in 2026 uses a proprietary blend format, which means all active ingredients share a single declared total weight without per-ingredient breakdown. For a product like JellyFil, that total is 82mg for nine ingredients. The label notes this is “equivalent to approximately 567mg of dry powders” — a concentration ratio reflecting that some ingredients are provided as standardized extracts rather than whole powder.
Even granting full extract potency, 567mg divided among nine ingredients averages roughly 63mg per ingredient before any unequal distribution. Research dosages for ashwagandha alone are 300–600mg. Research dosages for maca are measured in grams. This is not evidence that the ingredients are inactive at lower doses — dose-response relationships vary by ingredient and individual — but it is an important context for evaluating how directly published research findings apply to a proprietary blend gummy.
For midlife women considering a product like this, the more honest framing is: you are receiving a low-dose botanical combination that includes several ingredients with women-relevant research, at dosages that are substantially below what clinical trials have typically studied. Whether that combination provides meaningful benefit is a question the published research cannot definitively answer for this specific product at this specific dose. That is not a knock — it is true of virtually all dietary supplements — but it is the honest context.
Who This Category of Product May Be Relevant For
Midlife women who are already managing their foundational wellness basics — adequate dietary protein, consistent sleep, stress management, resistance training — and are interested in botanical adaptogen support may find the ashwagandha and maca components of these formulas worth considering on their own, in products that disclose per-ingredient doses. Ashwagandha in particular has a meaningful women-specific evidence base for stress adaptation and cortisol modulation. Maca has modest but real evidence for perimenopausal symptom support.
If the specific interest is in those adaptogenic components, a dedicated ashwagandha or maca supplement with transparent dosing may serve that goal better than a multi-ingredient male vitality gummy where the doses are undisclosed and spread across nine ingredients. For midlife women who are interested in JellyFil specifically — its formula, pricing, distributor, and refund policy — our complete product review is at JellyFil Review 2026: What the Label Shows.
Who Should Not Take These Products Without Provider Review
Women with thyroid conditions should not take ashwagandha-containing supplements without provider review. Published case reports document ashwagandha-associated thyroid hormone changes, and thyroid conditions are more prevalent in midlife women than in any other demographic. Women taking warfarin or other anticoagulants should flag the green tea extract component. Women with hormone-sensitive conditions (estrogen-receptor-positive breast cancer history, endometriosis, uterine fibroids) should discuss the horny goat weed (icariin/phytoestrogen) component with their provider before use. Full interaction and contraindication detail is in our Male Vitality Supplement Safety Guide 2026.
The Metabolism Connection: Why Some Midlife Women Find This Category
A meaningful subset of women who search for male vitality supplements in midlife is not specifically looking for libido support — they are looking for energy, stamina, and metabolic support that the weight management supplement category has not delivered. The adaptogen stack (ashwagandha, maca) combined with a mild stimulant (caffeine via green tea or standalone caffeine) addresses the energy and stress-resilience component of midlife metabolic change from a different angle than the ACV/BHB gummy category. Whether you arrive at this category through weight management searches or energy searches, the ingredient analysis in this article — and the full research breakdown in our JellyFil Ingredients: What Each Botanical Shows in Published Research — applies to the same question: what is the evidence for these specific ingredients for your specific goals?
Frequently Asked Questions
Can women take male vitality gummies?
Dietary supplements marketed as male vitality products are not regulated differently for men versus women under DSHEA. Women can legally take these products, but the key question is whether the ingredients have relevant published research for women's physiology — and whether any ingredients are contraindicated with medications common in midlife. Each ingredient should be evaluated separately before use.
Does ashwagandha have research for women over 40?
Yes. Ashwagandha (Withania somnifera) has been studied in women for stress response and cortisol reduction. Published trials have used dosages of 300–600mg of standardized root extract daily. The key caveat: most male vitality gummies contain ashwagandha in an undisclosed amount within a small proprietary blend, which may not match the doses studied.
What is maca root used for in women's health?
Maca root (Lepidium meyenii) has been studied in postmenopausal women for mood, energy, and sexual function. Some small trials suggest benefits for climacteric symptoms. Dosages studied have typically ranged from 1.5 to 3.5 grams daily of whole maca powder — substantially higher than what a small proprietary blend would deliver.
Should women with thyroid conditions take ashwagandha?
Women with thyroid conditions should consult their healthcare provider before taking ashwagandha. Published case reports document ashwagandha-associated changes in thyroid hormone levels. This is a relevant interaction for midlife women, among whom thyroid conditions are more prevalent.
Are male vitality gummy ingredients safe during perimenopause?
Most botanical ingredients in this category — ashwagandha, maca, green tea extract — are generally well tolerated in healthy adults. However, some ingredients have documented interactions with medications frequently used in midlife, including thyroid medications, blood pressure medications, and blood thinners. A healthcare provider review is appropriate before starting any supplement during perimenopause.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult your healthcare provider before starting any supplement.